Microglial activation and neuroinflammation in Alzheimer's disease: a critical examination of recent history

Related Experiment Video

Updated: Jun 12, 2026

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling (q3DISM) of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

Wolfgang J Streit1

  • 1Department of Neuroscience, University of Florida College of Medicine Gainesville, FL, USA.

Frontiers in Aging Neuroscience
|June 26, 2010
PubMed

Insights

Alzheimer's disease (AD) is not caused by neuroinflammation. This paper argues the prevailing AD neuroinflammation theory is flawed, tracing its origins to faulty scientific reasoning in the late 20th century.

Area of Science:

  • Neuroscience
  • Pathology
  • Medical History

Background:

  • Alzheimer's disease (AD) pathogenesis is widely attributed to neuroinflammation.
  • Activated microglia produce neurotoxic substances, driving neurodegeneration in AD.
  • Numerous clinical trials targeting neuroinflammation in AD have yielded disappointing results.

Purpose of the Study:

  • To challenge the established neuroinflammation hypothesis of Alzheimer's disease.
  • To critically examine the historical development of the AD neuroinflammation theory.
  • To propose an alternative perspective on AD pathogenesis.

Main Methods:

  • Historical analysis of scientific literature and research trends from the 1980s and 1990s.
  • Critical review of the evidence supporting the neuroinflammation hypothesis.
  • Reconstruction of the sequence of events leading to the AD neuroinflammation theory's prominence.

Main Results:

  • The current understanding of AD as an inflammatory condition is based on a potentially flawed theoretical framework.
  • Key research decisions and interpretations during the 1980s-1990s may have inadvertently promoted the neuroinflammation hypothesis.
  • The lack of success in anti-inflammatory drug trials suggests a fundamental issue with the underlying theory.

Conclusions:

  • Alzheimer's disease is unlikely to be primarily an inflammatory condition.
  • The historical trajectory of AD research has been significantly influenced by the neuroinflammation hypothesis.
  • Re-evaluation of AD pathogenesis is necessary, moving beyond the current neuroinflammatory paradigm.
Keywords:
agingamyloidchronic inflammationcytokinesmajor histocompatibility complex antigens

More Related Videos

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques10:52

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...